Drug intelligence / Profile preview

Zenstral PMS

Development stage
Preclinical
Lead developer
University Lab Technologies
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

**Zenstral PMS** is an oral fixed-dose nutraceutical caplet developed initially by University Lab Technologies and subsequently promoted by University Health Industries for premenstrual syndrome. The product combines standardized *Vitex agnus-castus* extract, magnesium oxide, and pyridoxine. Its proposed activity is driven principally by chasteberry's dopaminergic and pituitary-related effects, while magnesium and vitamin B6 provide nutritional support relevant to neuromuscular and neurotransmitter function. Public promotional materials described it as a patent-pending supplement for relief of PMS-associated physical and cyclical mood symptoms, rather than as an approved pharmaceutical treatment. ([businesswire.com](https://www.businesswire.com/news/home/20080428005198/en/University-Health-Industries-Launches-National-Television-Commercial))

Brand names
Zenstral PMS
02

Targets

DRD2 (Dopamine D2 Receptor)

Beyond the preview

Go deeper on Zenstral PMS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zenstral PMS.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call